Mycobacterium tuberculosis
Gates Foundation Awards ProteinLogic, Stellenbosch University $1.35M for TB Treatment Monitoring
The partners will use the money to develop ProteinLogic's ImmiPrint testing technology for the monitoring of TB patients during antimicrobial treatments.
The multi-year project led by FIND is currently evaluating three end-to-end solutions through clinical studies.
The firm has obtained CE marking for its automated, sample-to-answer Vidas TB-IGRA test for latent TB and is preparing a submission for FDA clearance.
BioMérieux Interferon Gamma Release Assay for Latent TB Gets CE Mark
The test is fully automated from sample to result interpretation and requires one whole-blood sample tube with no manual sample preparation necessary.
The WHO and FIND are supporting NGS-based testing in low-resource settings, while a resistance testing program at New York State's Wadsworth Center has matured.
Jan 7, 2020
Dec 23, 2019
Sep 25, 2019
Jul 25, 2019
Jun 28, 2019
Jun 12, 2019
Jan 31, 2019
Aug 30, 2017